Symbiont

Symbiont develops blockchain-based smart securities and financial contract platforms that enable the issuance, management, and settlement of digital financial instruments on a secure, institutional-grade distributed ledger infrastructure. The company provides a platform for creating programmable financial contracts—smart securities—that automate lifecycle events including issuance, corporate actions, coupon payments, and settlement through self-executing code on the blockchain. Symbiont's technology addresses inefficiencies in traditional financial markets by reducing operational complexity, eliminating intermediary costs, increasing transparency, and enabling real-time settlement for asset classes including syndicated loans, private equity, structured products, and other complex financial instruments. The platform incorporates institutional features including privacy controls, regulatory compliance tools, audit trails, and integration with existing financial infrastructure. Symbiont partners with major financial institutions and exchanges to bring blockchain-based solutions to capital markets, with backing from Nasdaq, Citi, and other prominent financial sector investors. The company's approach focuses on applying blockchain technology to improve back-office operations, reduce counterparty risk, and create new possibilities for financial product innovation in a regulated environment. Founded in 2013 and headquartered in New York City, United States, Symbiont has raised approximately $31 million at the Series B stage from investors including Nasdaq, Citi, Galaxy, Raptor Group, Medici Ventures, SenaHill Partners, Fenbushi Capital, and DHVC.